In future, further investigations into the expression profiles of TRIB3 and NQO1 in patients’ blood-derived exosomes should be performed to provide novel insights into early diagnosis, prognostic prediction, and the development of tailored drug treatment regimens for HCC. The gene discussed is TRIB3; the disease is hepatocellular carcinoma.